Capsugel Unveils New Spray-Dried Dispersion Commercial Manufacturing Facility
Capsugel it has completed construction of a new pharmaceutical spray-dried dispersion (SDD) commercial manufacturing facility at its site in Bend, Ore. The completion represents the final phase of a 2-year, $25 million investment to expand Capsugel’s commercial SDD capability at the site. With the expansion complete, Capsugel has the largest integrated pharmaceutical SDD technology capability in North America.
“This investment reflects Capsugel’s strategy to leverage our science- and engineering-based expertise to enable innovative dosage forms that improve the lives of patients and consumers,” said Amit Patel, President, Capsugel Dosage Form Solutions. “Capsugel continues to expand our capacity and capabilities to support a growing pipeline of customer projects from early-stage development all the way through late-stage clinical and commercial manufacture.”
Bend Research, a division of Capsugel Dosage Form Solutions, has a proven 20-year track record with SDD technology and unparalleled experience in formulating more than 1000 compounds. Since acquiring Bend Research, Capsugel has added two commercial-scale spray dryers, bringing the total number of commercial-scale units on its Bend campus to three. This expansion adds to Capsugel’s extensive infrastructure and industry-leading science in pre-clinical and early clinical development to provide an integrated offering for feasibility, development, late-stage clinical and commercial manufacture of spray-dried drug product intermediates. The new units use innovative dryer design and manufacturing plant technology to offer a significantly improved product throughput that minimizes cycle times and maximizes productivity. The newest unit, which is designed to accommodate high-potency compounds, will become fully operational later this year.
“We have taken the R&D competencies on which Bend Research has built its reputation and extended them to commercial manufacture, which is very exciting,” said Jim Nightingale, Managing Director of Bend Research. “With our improved throughput levels, high-potency capabilities, and a commercial facility co-located with R&D, we are positioning ourselves as a partner of choice for pharmaceutical customers. As a result, we are collaborating with customers to advance an ever widening range of promising molecules.”
SDD technology is one of many bioavailability enhancement approaches — including hot-melt-extruded amorphous dispersions, lipid-based formulations and nanoparticle technologies — available at Capsugel to enable the delivery of challenging molecules. Capsugel’s specialized expertise around the world helps customers select from a broad spectrum of development solutions and commercial manufacturing capabilities to find the right solution for their products and improve the delivery of medicines and nutritionals.
Bend Research is Capsugel’s center of excellence for bioavailability enhancement, modified release, other technology platforms and pharmaceutical R&D. The expanded facility, which has already created more than 20 new jobs in the past year, is expected to create an additional 20 full-time positions in the second half of 2015 and is designed to accommodate future capacity additions.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance